Blood Bank of Delmarva, Christiana, and New York Blood Center (NYBC) announced a merger of operations.
The new partnership brings together the complementary strengths of BBD and NYBC to deliver a broad range of blood banking expertise that will position both organizations to deliver next generation blood banking innovations, a release stated.
“This is an exceptional moment for our companies and the communities we serve,” said BBD CEO John Ferretti. “In today’s increasingly challenging and evolving blood banking environment it is imperative that like-minded organizations work together to improve access to safe blood products. This merger will ensure BBD’s long-term success in a challenging healthcare environment.”
Day-to-day operations at the organizations will not be impacted. BBD will continue to operate under its own name and will continue to serve customers in Delaware, New Jersey, Pennsylvania, Maryland and elsewhere.
Ferretti will continue as CEO of the Delmarva entity. BBD’s blood donors and volunteers will see no changes. Customers will have access to a broader portfolio of blood products and services, the release stated.
Christopher D. Hillyer, M.D., CEO of NYBC, said: “We’re extremely pleased to be partnering with such an excellent blood center. NYBC and BBD have a remarkable alignment of mission, vision and talent. We look forward to working together to ensure the finest customer-focused service for our hospitals and patients. We welcome BBD to the NYBC family.” With this merger Dr. Hillyer will become President of BBD.
NYBC is known for its research and product development capabilities. This will allow BBD to offer new services, skills and products throughout its service area, including immunohematology and cellular therapy lab services that BBD currently does not offer.
Nonprofit mergers have been widespread in Delaware and the region. In another area, financial services, the association representing credit unions in Delaware merged with a larger New England group.
